Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep 15:10:1254306.
doi: 10.3389/fcvm.2023.1254306. eCollection 2023.

Predictors and prognostic implications of hospital-acquired pneumonia in patients admitted for acute heart failure

Marija Polovina  1   2 , Milenko Tomić  1 , Mihajlo Viduljević  1 , Nataša Zlatić  1 , Andrea Stojićević  1 , Danka Civrić  1 , Aleksandra Milošević  1   2 , Gordana Krljanac  1   2 , Ratko Lasica  1   2 , Milika Ašanin  1   2
Affiliations

Predictors and prognostic implications of hospital-acquired pneumonia in patients admitted for acute heart failure

Marija Polovina et al. Front Cardiovasc Med. .

Abstract

Introduction: Data on predictors and prognosis of hospital acquired pneumonia (HAP) in patients admitted for acute heart failure (AHF) to intensive care units (ICU) are scarce. Better knowledge of these factors may inform management strategies. This study aimed to assess the incidence and predictors of HAP and its impact on management and outcomes in patients hospitalised for AHF in the ICU.

Methods: this was a retrospective single-centre observational study. Patient-level and outcome data were collected from an anonymized registry-based dataset. Primary outcome was in-hospital all-cause mortality and secondary outcomes included length of stay (LOS), requirement for inotropic/ventilatory support, and prescription patterns of heart failure (HF) drug classes at discharge.

Results: Of 638 patients with AHF (mean age, 71.6 ± 12.7 years, 61.9% male), HAP occurred in 137 (21.5%). In multivariable analysis, HAP was predicted by de novo AHF, higher NT proB-type natriuretic peptide levels, pleural effusion on chest x-ray, mitral regurgitation, and a history of stroke, diabetes, and chronic kidney disease. Patients with HAP had a longer LOS, and a greater likelihood of requiring inotropes (adjusted odds ratio, OR, 2.31, 95% confidence interval, CI, 2.16-2.81; p < 0.001) or ventilatory support (adjusted OR 2.11, 95%CI, 1.76-2.79, p < 0.001). After adjusting for age, sex and clinical covariates, all-cause in-hospital mortality was significantly higher in patients with HAP (hazard ratio, 2.10; 95%CI, 1.71-2.84; p < 0.001). Patients recovering from HAP were less likely to receive HF medications at discharge.

Discussion: HAP is frequent in AHF patients in the ICU setting and more prevalent in individuals with de novo AHF, mitral regurgitation, higher burden of comorbidities, and more severe congestion. HAP confers a greater risk of complications and in-hospital mortality, and a lower likelihood of receiving evidence-based HF medications at discharge.

Keywords: acute heart failure; heart failure treatment; hospital acquired pneumonia; intensive care unit; mortality.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer AD declared a past co-authorship with the author RL to the handling editor.

Figures

Figure 1
Figure 1
Kaplan-Meier time-to-event curve for in-hospital all-cause death according to the presence of hospital acquired pneumonia.
Figure 2
Figure 2
Median length of hospital stay in patients with (red) and without (blue) hospital acquired pneumonia.
See this image and copyright information in PMC

References

    1. Jackson S, Tong X, King R, Loustalot F, Hong Y, Ritchey M. National burden of heart failure events in the United States, 2006 to 2014. Circ Heart Fail. (2018) 11(12):E004873. 10.1161/CIRCHEARTFAILURE.117.004873 - DOI - PMC - PubMed
    1. Seferović P, Vardas P, Jankowska E, Maggioni A, Timmis A, Milinković I, et al. The heart failure association atlas: heart failure epidemiology and management statistics 2019. Eur J Heart Fail. (2021) 23(6):906–14. 10.1002/ejhf.2143 - DOI - PubMed
    1. Spinar J, Parenica J, Vitovec J, Widimsky P, Linhart A, Fedorco M, et al. Baseline characteristics and hospital mortality in the acute heart failure database (ahead) main registry. Critical Care. (2011) 15(6):R291. 10.1186/cc10584 - DOI - PMC - PubMed
    1. Lombardi C, Peveri G, Cani D, Latta F, Bonelli A, Tomasoni D, et al. In-hospital and long-term mortality for acute heart failure: analysis at the time of admission to the emergency department. Esc Heart Fail. (2020) 7(5):2650–61. 10.1002/ehf2.12847 - DOI - PMC - PubMed
    1. Dokoupil J, Hrečko J, Čermáková E, Adamcová M, Pudil R. Characteristics and outcomes of patients admitted for acute heart failure in a single-centre study. Esc Heart Fail. (2022) 9(4):2249–58. 10.1002/ehf2.13759 - DOI - PMC - PubMed